Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma

Oncogene

Volumn 24, Issue 6, 2005, Pages 1043-1052

  Petrella, Brenda L ^a   Lohi, Jouko ^b   Brinckerhoff, Constance E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

HIF 2 ; MT1 MMP; Renal cell carcinoma; Von Hippel Lindau

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MATRIX METALLOPROTEINASE 14; TRANSCRIPTION FACTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HYPOXIA INDUCIBLE FACTOR 2, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR 2, ALPHA SUBUNIT; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

ALPHA CHAIN; ARTICLE; BINDING SITE; CANCER INVASION; CAUSE OF DEATH; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; UPREGULATION; VON HIPPEL LINDAU DISEASE; BIOSYNTHESIS; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; KIDNEY TUMOR; MOLECULAR GENETICS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 13944252559     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208305     Document Type: Article

References (46)

1. Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, Eliopoulos N, Galipeau J and Beliveau R. (2003). Stem. Cells, 21, 337-347.
2. Barry RE and Krek W. (2004). Trends Mol. Med., 10, 466-472.
3. Bartolome RA, Galvez BG, Longo N, Baleux F, Van Muijen GN, Sanchez-Mateos P, Arroyo AG and Teixido J. (2004). Cancer Res., 64, 2534-2543.
4. Bogenrieder T and Herlyn M. (2003). Oncogene, 22, 6524-6536.
5. Egeblad M and Werb Z. (2002). Nat. Rev. Cancer, 2, 161-174.
6. Gaidarova S and Jimenez SA. (2002). J. Biol. Chem., 277, 38737-38745.
7. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC and Harris AL. (2001). Br. J. Cancer, 85, 881-890.
8. Harris AL. (2002). Nat. Rev. Cancer, 2, 38-47.
9. Hes FJ, van der Luijt RB and Lips CJ. (2001). Neth. J. Med., 59, 225-234.
10. Hotary K, Allen E, Punturieri A, Yana I and Weiss SJ. (2000). J. Cell. Biol, 149, 1309-1323.
11. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW and Weiss SJ. (2003). Cell, 114, 33-45.
12. Iida J, Wilhelmson KL, Price MA, Wilson CM, Pei D, Furcht LT and McCarthy JB. (2004). J. Invest. Dermatol., 122, 167-176.
13. Iliopoulos O, Kibel A, Gray S and Kaelin Jr WG. (1995). Nat. Med., 1, 822-826.
14. Jain S, Maltepe E, Lu MM, Simon C and Bradfield CA. (1998). Mech. Dev., 73, 117-123.
15. Jiang BH, Rue E, Wang GL, Roe R and Semenza GL. (1996). J. Biol. Chem., 271, 17771-17778.
16. Kaelin Jr WG. (2002). Nat. Rev. Cancer, 2, 673-682.
17. Kitagawa Y, Kunimi K, Uchibayashi T, Sato H and Namiki M. (1999). J. Urol., 162, 905-909.
18. Kondo K, Kim WY, Lechpammer M and Kaelin Jr WG. (2003). PLoS Biol., 1, E83.
19. Kondo K, Klco J, Nakamura E, Lechpammer M and Kaelin Jr WG. (2002a). Cancer Cell, 1, 237-246.
20. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T, Sugahara T and Takigawa M. (2002b). Carcinogenesis, 23, 769-776.
21. Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM, Stearman R, Vasselli JR, Stetler-Stevenson WG, Kaelin Jr WG, Linehan WM, Klausner RD, Gnarra JR and Vande Woude GF. (1999). Mol. Cell. Biol., 19, 5902-5912.
22. Lehti K, Lohi J, Valtanen H and Keski-Oja J. (1998). Biochem. J., 334 (Part 2), 345-353.
23. Linehan WM, Walther MM and Zbar B. (2003). J. Urol., 170, 2163-2172.
24. Lohi J, Lehti K, Valtanen H, Parks WC and Keski-Oja J. (2000). Gene, 242, 75-86.
25. Maher ER and Kaelin Jr WG. (1997). Medicine (Baltimore), 76, 381-391.
26. Maquoi E, Sounni NE, Devy L, Olivier F, Frankenne F, Krell HW, Grams F, Foidart JM and Noel A. (2004). Clin. Cancer Res., 10, 4038-4047.
27. Maranchie JK, Vasselli JR, Riss J, Bonifacino JS, Linehan WM and Klausner RD. (2002). Cancer Cell., 1, 247-255.
28. Martin B, Vaquero A, Priebe W and Portugal J. (1999). Nucleic Acids Res., 27, 3402-3409.
29. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ. (1999). Nature, 399, 271-275.
30. McCawley LJ and Matrisian LM. (2001). Curr. Opin. Cell. Biol., 13, 534-540.
31. Miki N, Ikuta M and Matsui T. (2004). J. Biol. Chem., 279, 15025-15031.
32. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I and Seiki M. (2002). EMBO J., 21, 3949-3959.
33. Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, Bazan HE and Bazan NG. (2004). Mol. Vis., 10, 341-350.
34. Richards FM, Webster AR, McMahon R, Woodward ER, Rose S and Maher ER. (1998). J. Intern. Med., 243, 527-533.
35. Sanchez-Elsner T, Botella LM, Velasco B, Langa C and Bernabeu C. (2002). J. Biol. Chem., 277, 43799-43808.
36. Sanchez-Elsner T, Ramirez JR, Sanz-Rodriguez F, Varela E, Bernabeu C and Botella LM. (2004). J. Mol. Biol., 336, 9-24.
37. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M. (1994). Nature, 370, 61-65.
38. Seiki M. (2003). Cancer Lett., 194, 1-11.
39. Singh AD, Shields CL and Shields JA. (2001). Sun. Ophthalmol., 46, 117-142.
40. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ and Krek W. (2003). Nature, 425, 307-311.
41. Strongin AY, Collier I, Bannikov G, Manner BL, Grant GA and Goldberg GI. (1995). J. Biol. Chem., 270, 5331-5338.
42. Tian H, McKnight SL and Russell DW. (1997). Genes Dev., 11, 72-82.
43. Ueda J, Kajita M, Suenaga N, Fujii K and Seiki M. (2003). Oncogene, 22, 8716-8722.
44. Visse R and Nagase H. (2003). Circ. Res., 92, 827-839.
45. Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ and Maxwell PH. (1998). Blood, 92, 2260-2268.
46. Zimmer M, Doucette D, Siddiqui N and Iliopoulos O. (2004). Mol. Cancer Res., 2, 89-95.